1 terminated. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Terminated 1 |
Follow INO 1001: new trials by email Literature Review of INO 1001 trials Research Report on INO 1001
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Intravenous INO-1001 Plus Oral Temozolomide to Evaluate Tolerability, Safety, and Pharmacokinetics in Patients With Melanoma INO-1001, temozolomide - Melanoma | Phase 1 | Terminated | Genentech, Inc. | 39 | 2005-10-01 | 2009-03-11 |
Deafness, Autosomal Recessive 53 (1) · Melanoma (1)
Genentech, Inc. (1)